Apyx Medical Corp Files 8-K: Material Definitive Agreement
Ticker: APYX · Form: 8-K · Filed: Nov 19, 2025 · CIK: 719135
| Field | Detail |
|---|---|
| Company | Apyx Medical Corp (APYX) |
| Form Type | 8-K |
| Filed Date | Nov 19, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $3.62, $9.4 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-filing
TL;DR
APYX Medical Corp signed a big deal. Details in 8-K.
AI Summary
On November 17, 2025, APYX Medical Corporation entered into a material definitive agreement. The company, formerly known as BOVIE MEDICAL Corp and AN CON GENETICS INC, is incorporated in Delaware and headquartered in Clearwater, Florida. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates a significant new contract or partnership for APYX Medical Corporation, which could impact its future revenue and strategic direction.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry inherent risks related to contract terms, performance obligations, and potential future disputes.
Key Numbers
- 001-31885 — Commission File Number (Identifies the company's filing with the SEC)
- 11-2644611 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- APYX Medical Corporation (company) — Registrant
- BOVIE MEDICAL Corp (company) — Former company name
- AN CON GENETICS INC (company) — Former company name
- November 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Clearwater, Florida (location) — Company headquarters
FAQ
What is the nature of the material definitive agreement entered into by APYX Medical Corporation?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on November 17, 2025.
When was APYX Medical Corporation incorporated?
APYX Medical Corporation was incorporated in Delaware.
What is the company's primary business address?
The company's primary business address is 5115 Ulmerton Road, Clearwater, Florida 33760.
What were APYX Medical Corporation's previous names?
APYX Medical Corporation was formerly known as BOVIE MEDICAL Corp and AN CON GENETICS INC.
What is the filing date of this 8-K report?
This 8-K report was filed as of November 19, 2025, with the earliest event reported on November 17, 2025.
Filing Stats: 834 words · 3 min read · ~3 pages · Grade level 10.3 · Accepted 2025-11-19 16:30:51
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share APYX Nasdaq Global Selec
- $3.62 — "Common Stock") at an offering price of $3.62 and grant to the Underwriter an option
- $9.4 m — from the Offering will be approximately $9.4 million, after deducting an underwriting
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex1-1.htm (EX-1.1) — 265KB
- ex5-1.htm (EX-5.1) — 16KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-2.htm (EX-99.2) — 15KB
- form8-k_001.jpg (GRAPHIC) — 7KB
- ex5-1_001.jpg (GRAPHIC) — 26KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- ex99-2_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-024279.txt ( ) — 655KB
- apyx-20251117.xsd (EX-101.SCH) — 3KB
- apyx-20251117_lab.xml (EX-101.LAB) — 33KB
- apyx-20251117_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. APYX MEDICAL CORPORATION Date: November 19, 2025 By: /s/ Matthew Hill Name: Matthew Hill Title: Chief Financial Officer, Secretary and Treasurer